References
- Aghaloo TL, Moy PK, Freymiller EG. Investigation of platelet-rich plasma in rabbit cranial defects: A pilot study. J Oral Maxillofac Surg 2002; 60: 1176–1181
- Amizuka N, Karaplis AC, Henderson HE. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol 1996; 175: 166–176
- Bautz F, Rafii S, Kanz L, Mohle R. Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment. Exp Hematol 2000; 28: 700–706
- Caffesse RG, Quinones CR. Polypeptide growth factors and attachment proteins in periodontal wound healing and regeneration. Periodontology 2000; 1: 69–79
- Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Madzarevic M, Kenney EB. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontol Res 2002; 37: 300–309
- Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22: 233–241
- Dai J, Rabie AB. VEGF: An essential mediator of both angiogenesis and endochondral ossification. J Dent Res 2007; 86: 937–950
- Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van Der Bent C, Papapoulos SE, Lowik CW. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002; 143: 1545–1553
- Garg AK. The use of platelet-rich plasma to enhance the success of bone grafts around dental implants. Dent Implant Update 2000; 11: 17–20
- Gordon JA, Tye CE, Sampaio AV, Underhill TM, Hunter GK, Goldberg HA. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone 2007; 41: 462–473
- Hu Z-M, Peel SA, Sandor GK, Clokie CM. The osteoinductive activity of bone morphogenetic protein (BMP) purified by repeated extracts of bovine bone. Growth Factors 2004; 22: 29–33
- Hu Z-M, Peel SA, Ho SK, Sándor GK, Clokie CM. Role of bovine bone morphogenetic proteins in bone matrix protein and osteoblast-related gene expression during rat bone marrow stromal cell differentiation. J Craniofac Surg 2005; 16: 1006–1014
- Hu Z-M, Peel SA, Ho SK, Sándor GK, Clokie CM. Platelet-rich plasma induces mRNA expression of VEGF and PDGF in rat bone marrow stromal cells differentiation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 107: 43–48, 2009
- Janssens K, ten Dijke S, Van Hul W. Transforming growth factor-beta1 to the bone. Endocr Rev 2005; 26: 743–774
- Kowanetz M, Ferrara N. Vascular endothelial growth factor signaling pathways: Therapeutic perspective. Clin Cancer Res 2006; 12: 5018–5022
- Kutzler MA, Solter PF, Hoffman WE, Holkmann D. Characterization and localization of alkaline phosphatase in canine seminal plasma and gonadal tissues. Theriogenology 2003; 60: 299–306
- Lecanda F, Avioli LV, Cheng SL. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 1997; 67: 386–396
- Lozada JL, Caplanis N, Proussaefs P, Willardsen J, Kammeyer G. Platelet-rich plasma application in sinus graft surgery: Part I-background and processing techniques. J Oral Implant 2001; 27: 38–42
- Marx RE. Platelet concentrate: A strategy for accelerating and improving bone regeneration. Bone Engineering, em squared incorporated, Toronto, Canada. 2000; 447–453
- Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgess KR. Platelet-rich plasma: Growth factor enhancement for bone graft. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 638–646
- Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Günther KP, Dehio C, Puhl W, Brenner RE. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 2002; 30: 472–477
- Miao D, He B, Jiang Y, Kobayashi T, Sorocéanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A, Genant HK, Kronenberg HM, Goltzman D, Karaplis AC. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 2005; 115: 2402–2411
- Mulligan MS, McDuffie JE, Shanley TP, Guo RF, Sarma JV, Warner RL, Ward PA. Role of rantes in experimental cardiac allograft rejection. Exp Mol Pathol 2000; 69: 167–174
- Nakashima M, Reddi AH. The application of bone morphogenetic proteins to dental tissue engineering. Nat Biotechnol 2003; 21: 1025–1032
- Okuda K, Kawase T, Momose M, Murata M, Saito Y, Suzuki H, Wolff LF, Yoshie H. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol 2003; 74: 849–857
- Reddi AH. Bone morphogenetic proteins: From basic science to clinical applications. J Bone Joint Surg Am 2001; 83-A(Suppl 1)S1–S6
- Ripamonti U, Crooks J, Rueger DC. Induction of bone formation by recombinant human osteogenic protein-1 and sintered porous hydroxyapatite in adult primates. Plast Reconstr Surg 2001; 107: 977–988
- Robiony M, Polini F, Costa F, Politi M. Osteogenesis distraction and platelet-rich plasma for bone restoration of the severely atrophic mandible: Preliminary results. J Oral Maxillofac Surg 2002; 60: 630–635
- Simpson DA, Murphy GM, Bhaduri T, Gardiner TA, Archer DB, Stitt AW. Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia. Biochem Biophys Res Commun 1999; 262: 333–340
- Sowa H, Kaji H, Iu MF, Tsukamoto T, Sugimoto T, Chihara K. Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblasts. J Biol Chem 2003; 278: 52240–52252
- Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn FW, Kawai S, Gallea S, Stiot V, Blanchet AM, Courtois B, Baron R, Rawadi G. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-β1 on osteoblast differentiation. Bone 2001; 29: 323–330
- Steigmann M, Garg AK. A comparative study of bilateral sinus lifts performed with platelet-rich plasma alone versus alloplastic graft material reconstituted with blood. Implant Dent 2005; 14: 261–266
- Thorn JJ, Sørensen H, Weis-Fogh U, Andersen A. Autologous fibrin glue with growth factors in reconstructive maxillofacial surgery. Int J Oral Maxillofac Surg 2004; 33: 95–100
- Turhani D, Weissenböck M, Stein E, Wanschitz F, Ewers R. Exogenous recombinant human BMP-2 has little initial effects on human osteoblastic cells cultured on collagen type I coated/noncoated hydroxyapatite ceramic granules. J Oral Maxillofac Surg 2007; 65: 485–493
- Urist MR, Iwata H. A solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 1979; 76: 1828–1832
- Xu L, Anderson AL, Lu Q, Wang J. Role of fibrillar structure of collagenous carrier in bone sialoprotein-mediated matrix mineralization and osteoblast differentiation. Biomaterials 2007; 28: 750–761
- Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Katagiri T, Wozney JM, Rosen V, Yoshiki S. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 1996; 220: 366–371
- Yeh LC, Lee JC. Co-transfection with the osteogenic protein (OP)-1 gene and the insulin-like growth factor (IGF)-I gene enhanced osteoblastic cell differentiation. Biochim Biophys Acta 2006; 1763: 57–63